Right Value Drug Stores recalls
Right Value Drug Stores has 8 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 28 Oct 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is labeling errors.
Total recalls8since 2015
Last 12 months1reported
Class I00% of total
Ongoing1latest 28 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 25%Class III 6 75%
Why right value drug stores is recalled
Product types
By year
Ongoing right value drug stores recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate, 200 mg/mL recalled by Right Value Drug Stores | Right Value Drug Stores | Sterility | Nationwide |
All right value drug stores recalls, newest first
8 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate, 200 mg/mL recalled by Right Value Drug Stores | Right Value Drug Stores | Sterility | Nationwide |
| Drug | CLASS III | LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine recalled | Right Value Drug Stores | Packaging Defects | Nationwide |
| Drug | CLASS III | Progesterone SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Tadalafil SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Progesterone SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Tadalafil SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Testosterone 200 mg Pellet recalled by Right Value Drug Stores | Right Value Drug Stores | Other | Nationwide |
| Drug | CLASS II | Glutathione 200 mg/mL Injectable recalled by Right Value Drug Stores | Right Value Drug Stores | Packaging Defects | KS, MO, TX |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.